Ionis Pharmaceuticals IONS Total debt
Total debt at other companies
Other financials
Where this comes from
Calculated from Ionis Pharmaceuticals’s reported figures.
Plus components not separately reported this period.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's total debt?
- Ionis Pharmaceuticals (IONS) reported total debt of $691.72M in Q1 2026.
- How has Ionis Pharmaceuticals's total debt changed year-over-year?
- Ionis Pharmaceuticals's total debt increased by 334.0% year-over-year, from $159.39M to $691.72M.
- What is the long-term trend for Ionis Pharmaceuticals's total debt?
- Over 5 years (2020 to 2025), Ionis Pharmaceuticals's total debt has grown at a 44.9% compound annual growth rate (CAGR), from $386.1M to $2.46B.
- What does total debt mean?
- The total amount of money a company owes to lenders and creditors through loans, bonds, and lease obligations.
- How do you interpret total debt?
- An increase suggests higher financial leverage and potential interest expense pressure, while a decrease indicates deleveraging and reduced solvency risk.
- How does total debt compare across companies?
- Biotech firms often maintain lower debt levels compared to capital-intensive industries, though debt usage varies based on commercialization stage and cash burn requirements.